The Redefining Early Stage Investments (RESI) Conference will be continuing its series during the JP Morgan healthcare conference week, in what will be RESI’s largest event yet on January 8 in San Francisco. RESI SF will offer early stage companies and investors an opportunity to get the most out of the biotech and medtech’s busiest week by the Bay.

Life Science Nation runs the Redefining Early Stage Investments (RESI) Conference series. This series aims to accelerate opportunities for biotech, medtech, diagnostics, and digital health early stage companies by providing a forum to source investors from around the globe, create relationships, and potentially, secure funding.